Xingyin Wealth Management Stable Income Eternal Profit Closed-end 2026 Period 189 Fixed Income Class begins distribution on February 28, with a performance benchmark of 2.35%-3.35%

LightningPacketLoss · 2026-03-20T17:03:02+00:00

XingYin Wealth Management has launched the Wenli Hengying closed-end fixed income wealth management product. The subscription period runs from February 28 to March 10, 2026, with a minimum investment of 200,000 yuan, an initial fundraising target of 500 million yuan, a risk rating of R2, a term of 566 days, and a performance benchmark of 2.35%-3.35% annualized. Specific information is subject to the product prospectus. Investment involves risks, so please proceed with caution.

LightningPacketLoss

2026-03-20 17:03:02

Abstract generation in progress

On February 28, according to Xingyin Wealth Management’s disclosure, the company’s fixed income product, the Wenli Hengying Closed-End 2026 (Issue 189), had a subscription/raising period from February 28, 2026, to March 10, 2026. The minimum purchase amount is 200,000 yuan, and the initial planned fundraising scale is 500 million yuan. The investment nature of the product is fixed income, with a risk rating of R2, a term of 566 days, and a performance benchmark of an annualized 2.35% to 3.35%. (Applicable to G-class shares)

Note: The performance benchmark is not the expected return and does not represent the product’s future performance or actual returns. It does not constitute a promise of product returns.

The above financial product information is for reference only. Please refer to the “Product Prospectus” and other sales documents for specifics. This article does not constitute any investment advice. Investors operate at their own risk.

(Xingyin Wealth Management)

(Edited by: Qian Xiaorui)

Keywords:

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.